11-4682200-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_030774.4(OR51E2):āc.512A>Gā(p.Asn171Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000465 in 1,614,038 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_030774.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR51E2 | NM_030774.4 | c.512A>G | p.Asn171Ser | missense_variant | 2/2 | ENST00000396950.4 | NP_110401.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR51E2 | ENST00000396950.4 | c.512A>G | p.Asn171Ser | missense_variant | 2/2 | 6 | NM_030774.4 | ENSP00000380153.3 | ||
OR51E2 | ENST00000641638.1 | c.512A>G | p.Asn171Ser | missense_variant | 2/2 | ENSP00000493442.1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152032Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000637 AC: 16AN: 251356Hom.: 0 AF XY: 0.0000736 AC XY: 10AN XY: 135842
GnomAD4 exome AF: 0.0000404 AC: 59AN: 1461890Hom.: 0 Cov.: 35 AF XY: 0.0000509 AC XY: 37AN XY: 727244
GnomAD4 genome AF: 0.000105 AC: 16AN: 152148Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74384
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 28, 2022 | The c.512A>G (p.N171S) alteration is located in exon 2 (coding exon 1) of the OR51E2 gene. This alteration results from a A to G substitution at nucleotide position 512, causing the asparagine (N) at amino acid position 171 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at